++
Source: Deming P. Viral hepatitis. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. 10th ed. New York, NY: McGraw-Hill; 2017. http://accesspharmacy.mhmedical.com/content.aspx?bookid=1861§ionid=132516044. Accessed April 10, 2017.
++
++
++
++
+++
PREVENTION AND SCREENING
++
++
Immunoglobulin (Ig)
Used when pre- or postexposure prophylaxis against HAV infection needed in persons for whom vaccination not an option.
Preferred for persons >40 years old, children <12 months, immunocompromised persons, and persons with chronic liver disease3
Most effective within 2 weeks after exposure1
Dosing:
May be given with HAV vaccine, but at different sites1
++
++